BR9407415A - Composições contendo um sal de aminoácido de agente antiinflamatório não-esteróide de ácido propiônico e caféina - Google Patents

Composições contendo um sal de aminoácido de agente antiinflamatório não-esteróide de ácido propiônico e caféina

Info

Publication number
BR9407415A
BR9407415A BR9407415A BR9407415A BR9407415A BR 9407415 A BR9407415 A BR 9407415A BR 9407415 A BR9407415 A BR 9407415A BR 9407415 A BR9407415 A BR 9407415A BR 9407415 A BR9407415 A BR 9407415A
Authority
BR
Brazil
Prior art keywords
caffeine
compositions containing
steroidal anti
inflammatory agent
amino acid
Prior art date
Application number
BR9407415A
Other languages
English (en)
Portuguese (pt)
Inventor
Sekhar Mitra
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9407415A publication Critical patent/BR9407415A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9407415A 1993-09-07 1994-08-24 Composições contendo um sal de aminoácido de agente antiinflamatório não-esteróide de ácido propiônico e caféina BR9407415A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11738993A 1993-09-07 1993-09-07
PCT/US1994/009582 WO1995007079A1 (fr) 1993-09-07 1994-08-24 Compositions contenant un sel d'acide amine d'agents anti-inflammatoires non steroidiens a base d'acide propionique et de la cafeine

Publications (1)

Publication Number Publication Date
BR9407415A true BR9407415A (pt) 1996-11-12

Family

ID=22372657

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9407415A BR9407415A (pt) 1993-09-07 1994-08-24 Composições contendo um sal de aminoácido de agente antiinflamatório não-esteróide de ácido propiônico e caféina

Country Status (6)

Country Link
EP (1) EP0717624A1 (fr)
JP (1) JPH09502202A (fr)
AU (1) AU7604194A (fr)
BR (1) BR9407415A (fr)
CA (1) CA2170485C (fr)
WO (1) WO1995007079A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017887A (en) * 1995-01-06 2000-01-25 Sibia Neurosciences, Inc. Peptide, peptide analog and amino acid analog protease inhibitors
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
PL330145A1 (en) * 1996-05-20 1999-04-26 Searle & Co Pharmaceutic preparations containing sodium and potassum oxaprosin salt as well as that formed from tris
JP2002510336A (ja) 1998-04-11 2002-04-02 エレカッパ・ユウロテラピッチ・ソシエタ・ペル・アチオニ 水溶性ケトプロフェン塩を含有する薬学的調製物及びその使用方法
NZ508490A (en) 1998-07-09 2003-08-29 Warner Lambert Co Use of a combination of a GABA analog and caffeine as an analgesic
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
US7863287B2 (en) * 2002-12-18 2011-01-04 Wyeth Llc Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines
US9149474B2 (en) 2011-11-23 2015-10-06 Michael Leighton Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant
US9629847B2 (en) 2011-11-23 2017-04-25 Michael Leighton Compositions and methods for treating symptoms of inflammatory related conditions using a combination of an antihistamine and a stimulant
EP3406239B1 (fr) * 2017-05-22 2021-10-20 Epifarma Srl Solutions de sel de lysine de kétoprofène agréables au goût

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
DE3328401A1 (de) * 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren Injizierbare loesung zur behandlung von entzuendungen
WO1991006295A1 (fr) * 1989-11-06 1991-05-16 Sepracor, Inc. Composition analgesique contenant du s(+) flurbiprofene optiquement pur
US4994604A (en) * 1990-01-10 1991-02-19 Merck & Co., Inc. Formation and resolution of ibuprofen lysinate
EP0663819A4 (fr) * 1992-09-29 1998-05-27 Merck & Co Inc Association d'ibuprofene et de cafeine.
EP0674517A1 (fr) * 1992-12-21 1995-10-04 The Procter & Gamble Company Compositions contenant de la cafeine et s(+)-ibuprofene ou s(+)-flurbiprofene ou s(+)-cetoprofene
AU5995094A (en) * 1993-01-29 1994-08-15 Merck & Co., Inc. Ciclobenzaprine-caffeine combination as a muscle relaxant

Also Published As

Publication number Publication date
JPH09502202A (ja) 1997-03-04
CA2170485C (fr) 2000-11-07
WO1995007079A1 (fr) 1995-03-16
AU7604194A (en) 1995-03-27
EP0717624A1 (fr) 1996-06-26
CA2170485A1 (fr) 1995-03-16

Similar Documents

Publication Publication Date Title
BR9407414A (pt) Composições contendo um sal de aminoácido de agente antiinflamatório não-esteroide de ácido propiônico e pelo menos um descongestionante um expectorante um anti-histamina e um antitussivo
BR9407415A (pt) Composições contendo um sal de aminoácido de agente antiinflamatório não-esteróide de ácido propiônico e caféina
HUT75089A (en) Compositions containing hyaluronic acid or it's derivatives and pharmaceutical active agent
KR950700085A (ko) 히알우론산과 nsaid함유 국소 조성물(topical composition containing hyaluronic acid and nsaids)
ITMI931324A1 (it) Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
IL113433A (en) Tablet formulations comprising amoxycillin and salts of clavulanic acid
AU3590489A (en) Use of gamma-hydroxybutyric acid salts in the treatment of alcoholism and pharmaceutical compositions thereof
EP0821054A3 (fr) Utilisation d'acides polyaspartiques et de leurs sels
SG50636A1 (en) Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof
GB9710644D0 (en) Asiatic acid derivatives it's manufacturing method and dermatological agent containing it
SG67283A1 (en) Sulphonic acid esters radiation-sensitive mixtures made therewith and their use
HU9502520D0 (en) Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives
KR920701213A (ko) 메틸렌디포스폰산 화합물 및 그것을 유효성분으로 하는 항염증제
DE69512929D1 (de) Salze von aminoalkoholen und diese enthaltende pharmazeutische zusammensetzungen
BR9305766A (pt) Composiçao aquosa de revestimento de autodeposiçao e revestimento de autodeposiçao
AU2988992A (en) Ammonium salt of pyrimidyl-substituted benzoic acid and its use as a herbicide
NO180794B (no) Nye amidoalkyl- og imidoalkylpiperaziner samt farmasöytisk preparat inneholdende slike forbindelser
AU7001796A (en) Benzoic acid compounds and medicinal use thereof
BR9300390A (pt) Composto de formula (i) ou um sal do mesmo farmaceuticamente aceitavel e processo para sua preparacao
IL108920A0 (en) Acyloxyhexanoic acid derivatives and pharmaceutical compositions containing them
NO951933L (no) Farmasöytiske formuleringer av ibuprofen
BR9307697A (pt) Composições contendo cafeína e s(+)-ibuprofeno ou s(+)-flubiprofeno ou s(+)-quetoprofeno
HUP0001866A3 (en) Salts of l-carnitine and alkanoyl-l-carnitine derivatives with 2-aminoethanesulfonic acid and pharmaceutical compositions containing them
GB9304745D0 (en) Use of pharmaceutical formulations
DE69420346D1 (de) Dermatologische präparate sowie neue benzoesäure derivate

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
CKFC Appeal: appeal against refusal